Tuberous Sclerosis Complex


Tuberous Sclerosis Complex: Clinical Diagnostic Criteria
Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
📺 Subscribe To My Channel and Get More Great Quizzes and Tutorials
https://www.youtube.com/channe....l/UC95TzSH1B_2EjaZMg
Join this channel to get access to perks:
https://www.youtube.com/channe....l/UC95TzSH1B_2EjaZMg
#FOAMped #MedEd #pediatrics
Disclaimer: All the information provided by Medical Education for Visual Learners and associated videos are strictly for informational purposes only. It is not intended as a substitute for medical advice from your health care provider or physician. It should not be used to overrule the advice of a qualified healthcare provider, nor to provide advice for emergency medical treatment. If you think that you or someone that you know may be suffering from a medical condition, then please consult your physician or seek immediate medical attention.


Long-time TS Alliance supporter Patricia Heaton discusses the Tuberous Sclerosis Alliance's Step Forward to Cure Tuberous Sclerosis Complex (TSC) walk program, which raises funds to fight tuberous sclerosis complex (TSC), a genetic disorder that causes tumors to form in vital organs. It is also the leading genetic cause of both epilepsy and autism. Find out more today at www.stepforwardtocuretsc.org.


Because participating in a clinical trial is an important personal decision, this video produced by the Tuberous Sclerosis Alliance offers basic information to help people with tuberous sclerosis complex (TSC) or other diseases make an informed decision. It also highlights why clinical trials are so crucial in gaining a better understanding of how to treat TSC. For more information, visit http://www.tsalliance.org/pages.aspx?content=332.


Cathy Evanochko is co-founder of Tuberous Sclerosis Canada and the mother of Kimberly who was diagnosed with tuberous sclerosis complex (TSC) in 1986 and with lymphangioleiomyomatosis (LAM) in 2007.
TSC impacts multiple organs of the body. Fortunately, the drug Afinitor (everolimus) works on many of those organs to improve the overall health of TSC patients. That is the good news. The bad news is that getting access to the drug in Canada requires both provincial and federal authorities to approve the drug for each indication. As such, a patient in one province may not have access to the drug simply due to their location and the main organ that is affected.
For more information, vist www.tscanada.ca/